Header Logo

Nell Lurain

Concepts (297)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cytomegalovirus
44
2020
79
5.170
Why?
Cytomegalovirus Infections
30
2020
82
4.270
Why?
DNA, Viral
22
2020
98
1.670
Why?
Antiviral Agents
19
2020
136
1.240
Why?
HIV Infections
12
2020
997
1.160
Why?
HIV-1
6
2015
451
1.040
Why?
Viral Load
10
2018
208
1.010
Why?
Drug Resistance, Viral
8
2014
40
0.870
Why?
Ganciclovir
15
2014
27
0.780
Why?
Antibodies, Viral
7
2018
87
0.660
Why?
Viral Proteins
9
2011
24
0.620
Why?
Cervix Uteri
5
2015
40
0.590
Why?
Coinfection
1
2015
29
0.520
Why?
Immunoglobulin G
5
2018
129
0.520
Why?
Humans
59
2020
29885
0.460
Why?
Phosphotransferases (Alcohol Group Acceptor)
5
2010
14
0.440
Why?
Polymerase Chain Reaction
6
2011
165
0.430
Why?
Viremia
4
2015
37
0.410
Why?
Antigens, CD
4
2015
102
0.400
Why?
Hepatitis B virus
1
2011
7
0.400
Why?
Alzheimer Disease
2
2013
2005
0.400
Why?
Hepatitis B
1
2011
18
0.390
Why?
Real-Time Polymerase Chain Reaction
1
2011
48
0.390
Why?
Genome, Viral
3
2010
12
0.380
Why?
DNA-Directed DNA Polymerase
8
2010
9
0.360
Why?
Lung Transplantation
4
2014
18
0.340
Why?
Receptors, Cell Surface
3
2015
50
0.330
Why?
Reagent Kits, Diagnostic
2
2007
19
0.310
Why?
Indicators and Reagents
1
2007
13
0.300
Why?
Female
24
2020
16473
0.290
Why?
Membrane Glycoproteins
4
2005
103
0.290
Why?
Organ Transplantation
3
2010
37
0.280
Why?
Virology
1
2006
15
0.270
Why?
Viral Envelope Proteins
4
2020
22
0.270
Why?
Molecular Sequence Data
8
2006
248
0.270
Why?
Drug Resistance, Microbial
9
2002
96
0.270
Why?
Chemokines, CXC
1
2006
5
0.270
Why?
Reproducibility of Results
6
2011
803
0.270
Why?
Antigens, Differentiation, Myelomonocytic
2
2015
16
0.270
Why?
Lipopolysaccharide Receptors
2
2015
27
0.270
Why?
Interferon-gamma
3
2015
111
0.260
Why?
T-Lymphocytes
4
2013
224
0.260
Why?
Hepacivirus
1
2006
75
0.260
Why?
Genital Diseases, Female
1
2004
10
0.240
Why?
Mutation
8
2009
399
0.240
Why?
Base Sequence
7
2009
135
0.240
Why?
Microbial Sensitivity Tests
7
2016
110
0.230
Why?
Foscarnet
8
2010
8
0.230
Why?
Amino Acid Sequence
6
2006
196
0.220
Why?
Genes, Viral
4
2016
10
0.220
Why?
Virus Replication
7
2020
92
0.210
Why?
Herpesvirus 4, Human
2
2020
14
0.210
Why?
RNA, Viral
5
2016
159
0.210
Why?
Leukocytes
2
2015
45
0.210
Why?
Fibroblasts
5
2013
93
0.200
Why?
Interleukin-6
2
2015
109
0.200
Why?
Sensitivity and Specificity
3
2011
558
0.200
Why?
Carotid Artery Diseases
2
2012
44
0.190
Why?
Genotype
5
2006
407
0.190
Why?
Adult
13
2020
8773
0.190
Why?
Male
17
2020
15870
0.180
Why?
Epstein-Barr Virus Infections
1
2020
19
0.180
Why?
DNA Virus Infections
1
2020
5
0.180
Why?
RNA Virus Infections
1
2020
5
0.180
Why?
RNA Viruses
1
2020
5
0.180
Why?
Salicylates
1
2020
7
0.180
Why?
DNA Viruses
1
2020
6
0.180
Why?
Isoxazoles
3
2010
16
0.180
Why?
Viral Fusion Proteins
1
2020
16
0.180
Why?
Lymphocyte Activation
3
2013
215
0.180
Why?
Receptors, Immunologic
2
2013
34
0.180
Why?
Hepatitis C
2
2013
66
0.170
Why?
Neurocognitive Disorders
1
2018
19
0.160
Why?
Anti-HIV Agents
2
2018
173
0.160
Why?
Inflammation
3
2015
346
0.160
Why?
Cytosine
2
2010
6
0.150
Why?
AIDS-Related Opportunistic Infections
2
2011
46
0.150
Why?
Middle Aged
11
2020
9958
0.150
Why?
Strophanthins
1
2016
1
0.140
Why?
Methionine
1
2016
3
0.140
Why?
Carotid Arteries
3
2012
54
0.140
Why?
Open Reading Frames
3
2006
12
0.140
Why?
Receptors, Tumor Necrosis Factor, Member 14
3
2013
3
0.140
Why?
Cells, Cultured
7
2015
678
0.140
Why?
Biomarkers
2
2018
703
0.130
Why?
Raltegravir Potassium
1
2015
9
0.130
Why?
Tissue Donors
1
1996
73
0.130
Why?
Genetic Variation
2
2009
110
0.130
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2006
154
0.130
Why?
Sulfates
1
2015
16
0.130
Why?
Organometallic Compounds
1
2015
13
0.130
Why?
Interleukin-17
1
2015
27
0.130
Why?
Disease Transmission, Infectious
1
2015
21
0.130
Why?
Interleukins
1
2015
37
0.130
Why?
Indoles
1
2015
51
0.130
Why?
Anti-Infective Agents, Local
1
2015
52
0.130
Why?
Sequence Homology, Amino Acid
5
1999
45
0.120
Why?
Hematopoietic Stem Cell Transplantation
2
2008
92
0.120
Why?
Cell Line
5
2016
297
0.120
Why?
Organ Culture Techniques
3
2011
29
0.120
Why?
Point Mutation
1
1994
29
0.120
Why?
Cohort Studies
4
2018
1954
0.110
Why?
Viral Structural Proteins
1
1992
4
0.110
Why?
Organophosphonates
2
2010
5
0.110
Why?
Mutagenesis, Site-Directed
1
1992
19
0.110
Why?
Phylogeny
3
2005
63
0.110
Why?
Receptors, Tumor Necrosis Factor
2
2005
33
0.110
Why?
T-Lymphocyte Subsets
1
2013
88
0.110
Why?
Killer Cells, Natural
1
2013
93
0.110
Why?
Neurofibrillary Tangles
1
2013
189
0.100
Why?
Decidua
1
2011
1
0.100
Why?
Tumor Necrosis Factor-alpha
3
2013
221
0.100
Why?
Infectious Disease Transmission, Vertical
1
2011
19
0.100
Why?
Immunosuppressive Agents
3
2010
135
0.100
Why?
Sequence Homology, Nucleic Acid
3
1999
16
0.100
Why?
Plasma
1
2011
34
0.100
Why?
Vascular Stiffness
1
2011
9
0.100
Why?
Amyloid beta-Peptides
1
2013
302
0.100
Why?
Antiretroviral Therapy, Highly Active
3
2020
146
0.100
Why?
Asymptomatic Diseases
1
2011
18
0.100
Why?
Green Fluorescent Proteins
2
2008
34
0.100
Why?
Genes, Reporter
2
2008
29
0.100
Why?
Lymphocyte Subsets
1
2011
30
0.090
Why?
Interleukin-8
2
2007
32
0.090
Why?
Sequence Analysis, DNA
1
2010
73
0.090
Why?
Toll-Like Receptors
2
2007
27
0.090
Why?
Gene Expression
4
2011
232
0.090
Why?
Anti-Infective Agents
1
2009
63
0.080
Why?
Artemisinins
1
2008
1
0.080
Why?
Skin
2
2003
118
0.080
Why?
Betaherpesvirinae
1
2008
1
0.080
Why?
Virion
2
2020
13
0.080
Why?
Lymphoid Tissue
1
2008
21
0.080
Why?
Foreskin
1
2007
1
0.080
Why?
Poly I-C
1
2007
6
0.080
Why?
Interferon-beta
1
2007
7
0.080
Why?
Receptors, Virus
2
2005
7
0.080
Why?
Chemokine CXCL1
1
2007
3
0.080
Why?
HIV Core Protein p24
1
2007
29
0.080
Why?
Culture Media
1
2007
38
0.080
Why?
Stromal Cells
1
2007
35
0.070
Why?
Lipopolysaccharides
1
2007
129
0.070
Why?
Phenotype
3
2003
363
0.070
Why?
Endothelial Cells
1
2007
65
0.070
Why?
HEK293 Cells
2
2020
69
0.070
Why?
Nucleic Acid Hybridization
1
1986
11
0.070
Why?
Laboratories
1
2006
26
0.070
Why?
Genomic Instability
1
2006
7
0.070
Why?
Glycosylation
1
2006
24
0.070
Why?
Herpesviridae
1
2005
2
0.070
Why?
Vaginosis, Bacterial
1
2005
31
0.060
Why?
Gene Expression Profiling
1
2006
159
0.060
Why?
Severe Combined Immunodeficiency
1
2004
1
0.060
Why?
Drug Resistance, Multiple, Viral
1
2004
1
0.060
Why?
Therapeutic Irrigation
1
2004
66
0.060
Why?
Saliva
1
2004
54
0.060
Why?
Vagina
1
2004
51
0.060
Why?
Enzyme-Linked Immunosorbent Assay
3
1992
131
0.060
Why?
Gene Amplification
1
2003
23
0.060
Why?
Aged, 80 and over
1
2013
4932
0.060
Why?
Cytomegalovirus Retinitis
1
2003
4
0.060
Why?
Aged
2
2014
9620
0.050
Why?
Opportunistic Infections
1
2002
9
0.050
Why?
Central Nervous System Viral Diseases
1
2002
1
0.050
Why?
Phosphorylation
2
2013
159
0.050
Why?
Case-Control Studies
2
2020
644
0.050
Why?
Flow Cytometry
3
2015
203
0.050
Why?
Amino Acid Substitution
1
2001
26
0.050
Why?
Models, Biological
2
2015
347
0.050
Why?
CD57 Antigens
2
2011
5
0.050
Why?
ADP-ribosyl Cyclase 1
2
2011
18
0.050
Why?
HLA-DR Antigens
2
2011
26
0.050
Why?
CD28 Antigens
2
2011
18
0.050
Why?
RNA, Messenger
2
2016
324
0.050
Why?
Animals
3
2020
4621
0.050
Why?
Vero Cells
1
2020
7
0.050
Why?
DNA Replication
1
2020
12
0.050
Why?
Tumor Necrosis Factor Ligand Superfamily Member 14
2
2013
2
0.050
Why?
Virus Internalization
1
2020
17
0.040
Why?
Leukocytes, Mononuclear
1
2020
98
0.040
Why?
Risk Factors
3
2014
2466
0.040
Why?
Astrocytes
1
2020
122
0.040
Why?
Dose-Response Relationship, Drug
2
2015
455
0.040
Why?
Mental Status and Dementia Tests
1
2018
81
0.040
Why?
Mucous Membrane
2
2009
40
0.040
Why?
Signal Transduction
2
2013
491
0.040
Why?
Cardiac Glycosides
1
2016
1
0.040
Why?
Genes, Immediate-Early
1
2016
2
0.040
Why?
Biological Transport, Active
1
2016
18
0.040
Why?
Molecular Structure
1
2016
28
0.040
Why?
Structure-Activity Relationship
1
2016
43
0.040
Why?
Time Factors
3
2011
1642
0.040
Why?
Restriction Mapping
1
1996
5
0.040
Why?
Sequence Alignment
1
1996
22
0.040
Why?
DNA Primers
1
1996
54
0.040
Why?
Models, Molecular
1
2016
81
0.030
Why?
Chromatography, High Pressure Liquid
2
1992
37
0.030
Why?
Postoperative Complications
1
2002
957
0.030
Why?
Complement Inactivator Proteins
1
1995
1
0.030
Why?
CD55 Antigens
1
1995
2
0.030
Why?
CD59 Antigens
1
1995
3
0.030
Why?
Human T-lymphotropic virus 1
1
1995
12
0.030
Why?
Immunization
1
2015
47
0.030
Why?
Administration, Intravaginal
1
2015
1
0.030
Why?
Cell Lineage
1
2015
30
0.030
Why?
Age Factors
1
2018
854
0.030
Why?
Cell Separation
1
2015
42
0.030
Why?
Immunophenotyping
1
2015
85
0.030
Why?
Cell Survival
1
2015
163
0.030
Why?
Mice, Inbred BALB C
1
2015
266
0.030
Why?
Cell Differentiation
1
2015
148
0.030
Why?
Cross-Sectional Studies
1
2018
970
0.030
Why?
Immunity, Innate
1
2015
90
0.030
Why?
Conserved Sequence
1
1994
7
0.030
Why?
Risk Assessment
2
2010
685
0.030
Why?
Simplexvirus
2
1999
9
0.030
Why?
CD56 Antigen
1
2013
8
0.030
Why?
Lymphotoxin-alpha
1
2013
7
0.030
Why?
Mitogen-Activated Protein Kinase 1
1
2013
17
0.030
Why?
Mitogen-Activated Protein Kinase 3
1
2013
22
0.030
Why?
GPI-Linked Proteins
1
2013
26
0.030
Why?
Interferon Type I
1
2013
19
0.030
Why?
Interleukin-2
1
2013
68
0.030
Why?
Treatment Outcome
2
2015
3557
0.030
Why?
Enzyme Activation
1
2013
112
0.030
Why?
Cloning, Molecular
1
1992
32
0.030
Why?
Demography
1
2013
78
0.030
Why?
Plasmids
1
1992
42
0.030
Why?
Nucleic Acid Synthesis Inhibitors
1
1992
7
0.030
Why?
Proto-Oncogene Proteins c-akt
1
2013
55
0.030
Why?
Transfection
1
1992
128
0.030
Why?
HIV Seropositivity
1
2013
95
0.030
Why?
Antigens, Viral
3
1998
19
0.030
Why?
Tunica Intima
1
2012
27
0.030
Why?
Antibodies, Neutralizing
1
2011
28
0.020
Why?
Cellular Senescence
1
2011
18
0.020
Why?
Fetal Proteins
1
2011
2
0.020
Why?
T-Box Domain Proteins
1
2011
6
0.020
Why?
Off-Label Use
1
2010
7
0.020
Why?
Models, Statistical
1
2011
133
0.020
Why?
Prevalence
1
2012
494
0.020
Why?
Heart Transplantation
1
2010
37
0.020
Why?
Pregnancy
1
2011
410
0.020
Why?
Palatine Tonsil
1
2009
7
0.020
Why?
CD8-Positive T-Lymphocytes
1
2011
174
0.020
Why?
CD4-Positive T-Lymphocytes
1
2011
223
0.020
Why?
Rectum
1
2009
61
0.020
Why?
In Vitro Techniques
1
2009
216
0.020
Why?
Ultrasonography
1
2011
227
0.020
Why?
Endothelium, Vascular
2
1999
64
0.020
Why?
Young Adult
1
2014
1968
0.020
Why?
Retrospective Studies
2
2010
3325
0.020
Why?
Virus Shedding
1
2007
15
0.020
Why?
Ligands
1
2007
58
0.020
Why?
Lymphocytes
1
2008
110
0.020
Why?
Deoxyribonuclease BamHI
1
1986
1
0.020
Why?
DNA Restriction Enzymes
1
1986
4
0.020
Why?
Herpesvirus 1, Human
1
2005
2
0.020
Why?
Binding, Competitive
1
2005
29
0.020
Why?
Prospective Studies
1
2011
1837
0.020
Why?
Binding Sites
1
2005
75
0.020
Why?
Immunity, Mucosal
1
2005
29
0.020
Why?
Toll-Like Receptor 2
1
2005
32
0.020
Why?
Toll-Like Receptor 4
1
2005
33
0.020
Why?
Cell Compartmentation
1
2004
11
0.020
Why?
Genes, Recessive
1
2004
8
0.020
Why?
Chromosome Aberrations
1
2004
15
0.020
Why?
Fatal Outcome
1
2004
60
0.020
Why?
Cell Line, Tumor
1
2005
273
0.010
Why?
DNA Mutational Analysis
1
2004
57
0.010
Why?
Membrane Proteins
1
2005
177
0.010
Why?
Child
1
2008
1379
0.010
Why?
Acquired Immunodeficiency Syndrome
1
2004
92
0.010
Why?
Transplantation Immunology
1
2002
4
0.010
Why?
Probability
1
2002
94
0.010
Why?
Infant
1
2004
542
0.010
Why?
Statistics, Nonparametric
1
2002
142
0.010
Why?
Drug Resistance
1
2002
58
0.010
Why?
Viral Plaque Assay
2
1992
2
0.010
Why?
Graft Rejection
1
2002
75
0.010
Why?
Graft Survival
1
2002
98
0.010
Why?
Reference Values
1
2002
232
0.010
Why?
Drug Therapy, Combination
1
2002
247
0.010
Why?
Survival Rate
1
2002
377
0.010
Why?
Transplantation, Homologous
1
2002
279
0.010
Why?
Umbilical Veins
1
1999
3
0.010
Why?
Blotting, Northern
1
1999
27
0.010
Why?
Codon
1
1999
8
0.010
Why?
Virulence
1
1999
15
0.010
Why?
Transcription, Genetic
1
1999
107
0.010
Why?
Uridine
1
1999
2
0.010
Why?
Drug Resistance, Multiple
1
1999
12
0.010
Why?
Immediate-Early Proteins
1
1998
6
0.010
Why?
Follow-Up Studies
1
2002
1855
0.010
Why?
Rats
1
1999
869
0.010
Why?
Phosphonoacetic Acid
1
1992
1
0.010
Why?
Drug Evaluation, Preclinical
1
1991
34
0.010
Why?
Lurain's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (297)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_